Tag: Ajanta
Browse our exclusive articles!
Ajanta Pharma’s Paithan plant gets five observations from USFDA; stock volatile
The inspection, conducted between April 13 and April 21, 2026, ended with the issuance of a Form 483 carrying five observations.By CNBCTV18.com April 22,...
Ajanta Pharma shares gain 5% after in-licensing agreement with Biocon for Semgalutide
Biocon will supply semaglutide to Ajanta Pharma for exclusive marketing in 23 countries and semi-exclusive marketing in thee countries across Africa, Centra Asia and...
Ajanta Pharma signs in-licensing pact with Biocon for marketing semaglutide in 26 countries
Ajanta Pharma Ltd on Tuesday (December 23) announced that it has entered into an in-licensing agreement with Biocon Ltd for semaglutide, a GLP-1 receptor...
Ajanta Pharma Q2: Profit rises 20%, revenue grows; interim dividend declared
Ajanta Pharma Ltd on Monday reported a 20% year-on-year rise in consolidated net profit at ₹260 crore for the quarter ended September 30, 2025,...
Ajanta Pharma says Income Tax search ongoing at offices, units
Specialty pharmaceutical company Ajanta Pharma Ltd on Wednesday (August 20) said the Income Tax Department conducted a search under the Income Tax Act, 1961,...
